Edwards Lifesciences (EW) CVP exercises 13,457 performance shares with 7,469 withheld for taxes
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Edwards Lifesciences Corp corporate officer Donald E. Bobo Jr. reported equity compensation activity tied to performance-based restricted stock units. On May 11, 2026, he exercised 13,457 Performance Rights, receiving the same number of shares of common stock.
To cover tax obligations, 7,469 common shares were withheld at $79.96 per share, a non-market disposition. After these transactions, he held 40,235.2532 common shares directly, plus 121,756 shares by trust and 38,969.5756 shares in a 401(k) indirectly. A prior grant from May 11, 2023 vested at 167.70% of its target following a three-year performance period, and the related Performance Rights now show 0 remaining, having been fully exercised.
Positive
- None.
Negative
- None.
Insider Trade Summary
13,457 shares exercised/converted
Mixed
5 txns
Insider
BOBO DONALD E JR
Role
CVP,Strategy/Corp Development
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Rights | 13,457 | $0.00 | -- |
| Exercise | Common Stock | 13,457 | $0.00 | -- |
| Tax Withholding | Common Stock | 7,469 | $79.96 | $597K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Performance Rights — 0 shares (Direct, null);
Common Stock — 40,235.253 shares (Direct, null);
Common Stock — 38,969.576 shares (Indirect, 401(k))
Footnotes (1)
- On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4. These Performance Rights expire on May 10, 2030.
Key Figures
Performance Rights exercised: 13,457 shares
Shares withheld for taxes: 7,469 shares at $79.96
Direct common shares after transactions: 40,235.2532 shares
+4 more
7 metrics
Performance Rights exercised
13,457 shares
Converted into common stock on May 11, 2026
Shares withheld for taxes
7,469 shares at $79.96
Tax-withholding disposition on May 11, 2026
Direct common shares after transactions
40,235.2532 shares
Direct ownership following exercise and withholding
Indirect trust holdings
121,756 shares
Common stock held indirectly by trust
Indirect 401(k) holdings
38,969.5756 shares
Common stock held through 401(k) plan
Vesting percentage of target RSUs
167.70%
Performance-based units vesting as of May 11, 2026
Remaining Performance Rights
0.0000 units
Balance after exercise of 13,457 units
Key Terms
restricted stock units, performance-based vesting requirements, Performance Rights, 401(k)
4 terms
restricted stock units financial
"granted a target number of shares covered by restricted stock units with performance-based vesting"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
performance-based vesting requirements financial
"restricted stock units with performance-based vesting requirements over a three-year performance period"
Performance Rights financial
"These Performance Rights expire on May 10, 2030."
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
401(k) financial
"total_shares_following_transaction":"38969.5756","direct_or_indirect":"I","nature_of_ownership":"401(k)""
A 401(k) is a type of retirement savings plan offered by employers that allows workers to set aside a portion of their paycheck before taxes are taken out. The money saved in a 401(k) can grow over time through investments, helping individuals build funds for their future retirement. It matters to investors because it provides a tax-advantaged way to save and invest for long-term financial security.
FAQ
What did Edwards Lifesciences (EW) executive Donald Bobo Jr. report in this Form 4?
Donald E. Bobo Jr. reported the exercise of 13,457 Performance Rights into common stock and a related tax-withholding disposition of 7,469 shares at $79.96 per share. These transactions reflect equity compensation activity rather than open-market buying or selling.
What was the size and nature of the tax withholding in the Edwards Lifesciences (EW) Form 4?
The filing shows 7,469 Edwards Lifesciences common shares withheld at $79.96 per share to satisfy tax obligations. This F-code transaction is a non-market disposition typically associated with vesting or exercise of equity awards, not an open-market sale decision.
What performance-based equity grant is referenced in this Edwards Lifesciences (EW) Form 4?
The Form 4 references a grant of restricted stock units with performance-based vesting made on May 11, 2023. After a three-year performance period, the board’s committee determined 167.70% of the target shares would vest as of May 11, 2026, and those vested shares are reflected here.
Are any Performance Rights still outstanding for Donald Bobo Jr. at Edwards Lifesciences (EW)?
The filing shows 13,457 Performance Rights exercised into common stock, leaving a remaining balance of 0.0000 Performance Rights. A footnote states these Performance Rights were scheduled to expire on May 10, 2030, but they have now been fully exercised and reported.